Kaposi Sarcoma
generalA malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).
36
Centers
15
Active Trials
$2.1B
Cancer Funding
Specific Cancer Types(2)
| Name | Centers |
|---|---|
| Sarcoma, Kaposi | 15 |
| Recurrent Kaposi Sarcoma | 10 |
Top Centers for Kaposi Sarcoma(36)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Clinical High-Volume Research Center | 77.0 |
| 2 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 62.9 |
| 3 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 61.6 |
| 4 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 60.8 |
| 5 | NCI Comprehensive Active Research Program | 60.8 |
| 6 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 60.3 |
| 7 | LSU LCMC Health Cancer CenterNew Orleans, LA Active Research Program | 59.0 |
| 8 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 57.7 |
| 9 | NCI Comprehensive Active Research Program | 56.4 |
| 10 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive Active Research Program | 55.1 |
| 11 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 55.0 |
| 12 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 55.0 |
| 13 | University of Illinois Cancer CenterChicago, IL Active Research Program | 55.0 |
| 14 | Cancer Center at IllinoisUrbana, IL Active Research Program | 55.0 |
| 15 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 53.8 |
| 16 | Active Research Program | 52.5 |
| 17 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 49.9 |
| 18 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive Active Research Program | 48.6 |
| 19 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 47.3 |
| 20 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 46.0 |
| 21 | NCI Comprehensive Active Research Program | 44.7 |
| 22 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 43.4 |
| 23 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 42.1 |
| 24 | NCI Comprehensive | 35.0 |
| 25 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 35.0 |
| 26 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 35.0 |
| 27 | 35.0 | |
| 28 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | — |
| 29 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | — |
| 30 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | — |
| 31 | Cedars-Sinai CancerLos Angeles, CA | — |
| 32 | Cleveland Clinic Cancer CenterCleveland, OH | — |
| 33 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | — |
| 34 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical | — |
| 35 | Boston University Cancer CenterBoston, MA | — |
| 36 | BC CancerVancouver, BC | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →